Biotie Therapies Oyj

HEL:BTH1V ISIN:FI0009011571

 
 

News

Biotie's VAP-1 Antibody Program To Proceed To Clinical Studies In Rheumatoid Arthritis And Psoriasis Patients

🕔6/18/2008 5:17:00 PM 920

Biotie Therapies Oyj BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE June 18, 2008 at 10.15 a.m.

Read Full Article▸
###

3,615 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 5) (Last 30 Days: 36) (Since Published: 3615) 

Company Data